The Endocrine Society recently updated its guidance on primary prevention of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes in those at metabolic risk.
An accompanying editorial called for broader international efforts to target cardiovascular risk through programs that encourage healthy lifestyles.
Patients were categorized into five groups: mild age-related diabetes, mild obesity-related diabetes, severe autoimmune diabetes, severe insulin-resistant diabetes, and severe insulin-deficient diabetes.
This month's quiz asks readers to evaluate a 64-year-old man with type 2 diabetes who has undergone coronary angiography after presenting with progressive exertional chest pain and shortness of breath.
In patients with acute ischemic stroke and hyperglycemia, a target glucose level of 80 to 130 mg/dL was associated with more hypoglycemia and no difference in functional outcomes compared to a target of 80 to 179 mg/dL.
An accompanying editorial said that while the study's finding is reassuring, it should be considered with caution, especially since high-risk patients and those with previous urinary tract infections (UTIs) were excluded.
The nasal powder is indicated for the emergency treatment of severe hypoglycemia in patients with diabetes ages 4 years and older.